Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Isoniazid (INH) Monotherapy (9 months for Latent TB Infection)
Treatment for Drug-susceptible tuberculosis
Typical Dosage: Isoniazid 300mg daily
Effectiveness
75%
Safety Score
65%
Clinical Trials
300
Participants
100K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
Isoniazid 300mg daily
Time to Effect
Prevention initiated within weeks, protective effect over years
Treatment Duration
9 months
Evidence Quality
HIGHNumber Needed to Treat (NNT)
15(Treat 15 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
200(Treat 200 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$200
Side Effect Mgmt:$50
Total Annual:$325
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$30,000/QALY
QALYs Gained
0.1
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov